One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Search from 250 M+ research papersSearch from 250 M+ research papers
Open Accesshttps://doi.org/10.1182/blood-2020-139181
Copy DOI Journal: Blood |  Publication Date: Nov 5, 2020 |
 Citations: 12 |
Affiliation: GlaxoSmithKline (United States), GlaxoSmithKline (United Kingdom), Instituto de Investigación Biomédica de Salamanca, Centro de Investigación del Cáncer, Alfred Health, Monash University, Royal Marsden Hospital, National and Kapodistrian University of Athens, Alexandra Hospital, University of Catania, University Hospital Ostrava, Hôpital Saint-Louis, Samsung Medical Center, Sungkyunkwan University, Research Triangle Park Foundation, Universität Hamburg, University Medical Center Hamburg-Eppendorf, São Germano Oncologia, Medical University of Silesia, Rocky Mountain Cancer CentersDREAMM-7: A Phase III Study of the Efficacy and Safety of Belantamab Mafodotin (Belamaf) with Bortezomib, and Dexamethasone (B-Vd) in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
